Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection
- 14 February 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 94 (5)
Abstract
ZIKV emerged as a vector-borne pathogen capable of causing illness in infected adults and congenital birth defects in infants born to mothers infected during pregnancy. Despite the decrease in ZIKV cases since the 2015-2016 epidemic, questions concerning the prevalence and longevity of protective immunity have left vulnerable communities fearful that they may become the center of next ZIKV outbreak. Although preexisting herd immunity in regions of past outbreaks may dampen the potential for future outbreaks to occur, we currently do not know the longevity of protective immunity to ZIKV after a person becomes infected. Here, we establish a new experimentally defined minimal length of protective ZIKV immunity. We show that five rhesus macaques initially infected with ZIKV 22 to 28 months prior to rechallenge elicit a durable immune response that protected from detectable plasma viremia. This study establishes a new minimal length of protective immunity.Keywords
All Related Versions
Funding Information
- U.S. Department of Health and Human Services (R01 AI116382)
- University of Wisconsin-Madison (NSF HRD-1612530)
This publication has 56 references indexed in Scilit:
- Synchrony of Sylvatic Dengue Isolations: A Multi-Host, Multi-Vector SIR Model of Dengue Virus Transmission in SenegalPLOS Neglected Tropical Diseases, 2012
- Comparison of Plaque- and Enzyme-Linked Immunospot-Based Assays To Measure the Neutralizing Activities of Monoclonal Antibodies Specific to Domain III of Dengue Virus Envelope ProteinClinical and Vaccine Immunology, 2012
- Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public healthNature Reviews Microbiology, 2011
- Yellow Fever: A Reemerging ThreatClinics In Laboratory Medicine, 2010
- Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trialThe Lancet, 2007
- Antibody to Dengue 1 Detected More Than 60 Years after InfectionViral Immunology, 2007
- Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDSJournal of Medical Primatology, 2005
- Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal AntiseraJournal of General Virology, 1989
- Acute lymphopenia, stress, and plasma cortisol.Archives of Disease in Childhood, 1975
- Zika Virus (I). Isolations and serological specificityTransactions of the Royal Society of Tropical Medicine and Hygiene, 1952